Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ACTG1 |
| Upstream (Parents) |
|---|
| (<<) BDH1 → ACTG1 |
| (<<) CYP4F2 → ACTG1 |
| (<<) PKM2 → ACTG1 |
| (<<) RBKS → ACTG1 |
| (<<) RDH16 → ACTG1 |
| (<<) RNASE4 → ACTG1 |
| (<<) RXRA → ACTG1 |
| (<<) SAA4 → ACTG1 |
| Downstream (Children) |
|---|
| ACTG1 → ADAM8 (>>) |
| ACTG1 → ANXA2 (>>) |
| ACTG1 → CSNK1D (>>) |
| ACTG1 → DYNLL1 (>>) |
| ACTG1 → EPN3 (>>) |
| ACTG1 → FERMT1 (>>) |
| ACTG1 → FGF3 (>>) |
| ACTG1 → FOS (>>) |
| ACTG1 → FUT4 (>>) |
| ACTG1 → GOT1 (>>) |
| ACTG1 → HGS (>>) |
| ACTG1 → HK2 (>>) |
| ACTG1 → INPP5D (>>) |
| ACTG1 → LGALS3 (>>) |
| ACTG1 → LRP3 (>>) |
| ACTG1 → MAFF (>>) |
| ACTG1 → MAPK13 (>>) |
| ACTG1 → MAT2A (>>) |
| ACTG1 → MTHFD2 (>>) |
| ACTG1 → NRG1 (>>) |
| ACTG1 → PLCB4 (>>) |
| ACTG1 → PTMA (>>) |
| ACTG1 → RPL23A (>>) |
| ACTG1 → RPS6KA5 (>>) |
| ACTG1 → S100A2 (>>) |
| ACTG1 → SHC2 (>>) |
| ACTG1 → SMURF2 (>>) |
| ACTG1 → TMSB10 (>>) |
| ACTG1 → TUBA1B (>>) |
| ACTG1 → TUBA1C (>>) |
